Abiopharma

🔍 Schlegel Stephen J. (Executive)

Company: American Well Corp (AMWL)

Report Date: 2026-06-16

Detailed Transactions and Holdings:

• Acquired 14,501 shares of Class A Common Stock (Direct)
  Date: 2026-06-16 | Code: A | equity_swap_involved: false | shares_owned_after: 69,054.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents a grant of restricted stock units, which vest on the earlier of (i) the day immediately preceding the date of the first annual meeting of the stockholders following the grant date and (ii) the first anniversary of the grant date.